Stock listing
NASDAQ:OXFD Oxford Immunotec Global PLC Stock
Follow Oxford Immunotec Global PLC into a list and get an email when it puts out news.
Last close · NASDAQ:OXFD
$21.99 USD
Close on Mar 10, 2021 · No longer trades
- Lowest – highest close
- $7.90 – $24.42 USDSince Nov 21, 2013 · lowest Jul 25, 2016 · highest Mar 7, 2014
Delisted NASDAQ:OXFD no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:OXFD
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Oxford Immunotec Global PLC on 6ix
- Decks
- 3 decks · latest Jan 7, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2019) | Investor deck | 19 slides | Jan 7, 2019 |
| Merger or Acquisition (September 2018) | Merger or acquisition | 9 slides | Sep 25, 2018 |
| Investor Presentation (January 2018) | Investor deck | 21 slides | Jan 8, 2018 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Herm Rosenman Other companies: Natera, Inc. (Director · Since at least Sep 14, 2018); VIVUS Inc (Director · Feb 20, 2020 – Feb 20, 2020 · Past); Constellation Alpha Capital Corp (Director · Aug 29, 2019 – Jun 1, 2023 · Past) | Director · Jun 18, 2019 – Mar 8, 2021 · Past |
| James R. Tobin Other companies: Lyra Therapeutics, Inc. (Lead Independent Director · Since at least Mar 4, 2022); TransMedics Group, Inc. (Director · Since at least Feb 9, 2021); Globus Medical, Inc. (Director · Since at least Jan 14, 2021) | Director · Mar 8, 2021 – Mar 8, 2021 · Past |
| Ronald Andrews Other companies: Plus Therapeutics, Inc. (Director · Since at least Mar 20, 2026); Precipio, Inc. (Director · Since at least Mar 1, 2021); Insight Molecular Diagnostics Inc. (Former CEO, Director · Jul 1, 2019 – Dec 1, 2022 · Past) | Director · Jun 18, 2019 – Mar 8, 2021 · Past |
| Andrew Scott Walton | Director · Nov 4, 2015 – Mar 8, 2021 · Past |
| Jeff R Schroeder | Chief Commercial Officer · Nov 21, 2013 – May 8, 2017 · Past |
| Richard M Altieri | Chief Financial Officer · Nov 21, 2013 – Jan 1, 2019 · Past |
Log in to ask 6ix AI your own questions about Oxford Immunotec Global PLC.